BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7352496)

  • 1. Intrauterine contraceptive device use and pelvic inflammatory disease.
    Kaufman DW; Shapiro S; Rosenberg L; Monson RR; Miettinen OS; Stolley PD; Slone D
    Am J Obstet Gynecol; 1980 Jan; 136(2):159-62. PubMed ID: 7352496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five years private practice experience of nulliparous women using copper IUD's.
    Smith RP; Goresky DM; Etchell DM
    Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of intrauterine devices. II. Intrauterine devices and pelvic inflammatory disease and ectopic pregnancy.
    Malhotra N; Chaudhury RR
    Obstet Gynecol Surv; 1982 Jan; 37(1):1-8. PubMed ID: 7054735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine devices and pelvic inflammatory disease: an international perspective.
    Farley TM; Rosenberg MJ; Rowe PJ; Chen JH; Meirik O
    Lancet; 1992 Mar; 339(8796):785-8. PubMed ID: 1347812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low risk of pelvic inflammatory disease in young never-pregnant women using Gravigard.
    Larsson B; Hagström B; Viberg L; Anker C; Hamberger L; Lindhe BA
    Contraception; 1979 Sep; 20(3):291-5. PubMed ID: 509955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings.
    Mumford SD; Kessel E
    Fertil Steril; 1992 Jun; 57(6):1151-76. PubMed ID: 1601137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic inflammatory disease and the intrauterine contraceptive device.
    Wright EA; Aisien AO
    Int J Gynaecol Obstet; 1989 Feb; 28(2):133-6. PubMed ID: 2563699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use.
    Buchan H; Villard-Mackintosh L; Vessey M; Yeates D; McPherson K
    Br J Obstet Gynaecol; 1990 Sep; 97(9):780-8. PubMed ID: 2242362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine contraceptive device and pelvic inflammatory disease.
    Toivonen J
    Ann Med; 1993 Apr; 25(2):171-3. PubMed ID: 8489756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to conception after IUD removal: importance of duration of use, IUD type, pelvic inflammatory disease and age.
    Andolsek L; Teeter RA; Kozuh-Novak M; Wheeler R; Fortney JA; Rosenberg MJ
    Int J Gynaecol Obstet; 1986 Jun; 24(3):217-23. PubMed ID: 2880761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine contraceptive devices. Complications associated with their use.
    Nagel TC
    Postgrad Med; 1983 Mar; 73(3):155-64. PubMed ID: 6828391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
    Larsson B; Rodau S; Patek E
    Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraception and the etiology of pelvic inflammatory disease: new perspectives.
    Senanayake P; Kramer DG
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 2):852-60. PubMed ID: 7008602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the use of intrauterine devices in nulliparous women.
    Graham S; Simcock BW
    Contraception; 1982 Oct; 26(4):323-46. PubMed ID: 6759026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of pelvic inflammatory disease in clinical trials with Cu-7 (intrauterine copper contraceptive): a statistical analysis.
    O'Brien FB; Stewart WC; Sturtevant FM
    Contraception; 1983 Feb; 27(2):111-22. PubMed ID: 6851553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of different types of intrauterine devices on the risk of pelvic inflammatory disease.
    Kaufman DW; Watson J; Rosenberg L; Helmrich SP; Miller DR; Miettinen OS; Stolley PD; Shapiro S
    JAMA; 1983 Aug; 250(6):759-62. PubMed ID: 6876331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine devices and pelvic inflammatory disease: recent developments.
    Grimes DA
    Contraception; 1987 Jul; 36(1):97-109. PubMed ID: 3311628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rise and fall of IUDS's: banning of IUD's in USA. Alarming interactions between IUD's and sexually transmitted diseases (STD).
    Krzyzaniak LT; Lotfy M
    Adv Contracept Deliv Syst; 1986 Jun; 2(2-3):112-58. PubMed ID: 12280505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.